Evidence map›Paper›PMID 40442463›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Network homeostasis: functional brain network alterations and relapse in remitted late-life depression.

Andrew R Gerlach, Helmet T Karim, Antonija Kolobaric, Brian D Boyd, Kevin Kahru, Robert T Krafty, Olusola Ajilore, Warren D Taylor, Carmen Andreescu

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  3. Article
  4. The new normal: neural network adaptations in late-life depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew R GerlachDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-4022-1356
Helmet T KarimDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Antonija KolobaricDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Brian D BoydDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, The Vanderbilt Center for Cognitive Medicine, Nashville, TN, USA.
Kevin KahruSchool of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Robert T KraftyDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
Olusola AjiloreDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0737-0437
Warren D TaylorDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, The Vanderbilt Center for Cognitive Medicine, Nashville, TN, USA.
Carmen AndreescuDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. andrcx@upmc.edu.ORCID http://orcid.org/0000-0003-3767-5127

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia RiskR01MH108509 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Carmen Andreescu · 2016 to 2026
$10.6M
CLINICAL RESEARCH TRAINING IN LATE-LIFE MOOD DISORDERST32MH019986 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Carmen Andreescu · 1997 to 2026
$6.9M
1/3-Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-life Depression (Rembrandt)R01MH121620 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TAYLOR, WARREN D · 2020 to 2024
$5.3M
Recurrence markers, cognitive burden and neurobiological homeostasis in latelife depression (REMBRANDT) - SupplementR01MH121619 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANDREESCU, CARMEN · 2020 to 2024
$5.1M
3/3-Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depressionR01MH121384 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AJILORE, OLUSOLA A. · 2020 to 2024
$3.0M
Machine Learning Models for Identifying Neural Predictors of TMS Treatment Response in MDDK01MH122741 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KARIM, HELMET TALIB · 2021 to 2025
$852k
Individual Multimodal Pathway Statistics for Predicting Treatment Response in Late-life DepressionK01MH133913 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Andrew Robert Gerlach · 2023 to 2026
$705k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NIMH NIH HHS K01 MH122741NIMH NIH HHS K01 MH133913NIMH NIH HHS R01 MH108509NIMH NIH HHS R01 MH121384NIMH NIH HHS R01 MH121619NIMH NIH HHS R01 MH121620NIMH NIH HHS T32 MH019986
6 · The paper itself

Abstract

Late-life depression (LLD) is highly recurrent and associated with disability and increased mortality. In this study, we aim to identify neurobiological factors that are prospectively associated with relapse risk in late-life depression. We recruited 145 older adults (age ≥ 60): 102 recently remitted LLD participants and 43 healthy comparisons. Participants underwent baseline MRI and evaluation of depression symptoms/status for up to 2 years. We evaluated intrinsic network connectivity for 111 participants (39 healthy comparisons, 47 stable remitted, 25 relapsed). Compared to healthy comparisons, LLD participants had lower connectivity within the somatomotor network and greater connectivity between the executive control and default mode networks (DMN). Lower connectivity of DMN to somatomotor and salience networks was associated with relapse. Overall, connectivity of relapse participants was more similar to healthy comparisons than connectivity of stable remitted participants was. We found robust differences in network functional connectivity between stable remitted and relapsed participants. We also found evidence of neural "scarring," or persistent functional network differences at baseline in all participants with a history of depression. Alterations in DMN connectivity were observed most prominently. Notably, the network structure of relapsed participants was more similar to healthy comparisons than stable remitted participants. These findings indicate that remission is associated with persistent functional network alterations while vulnerability to relapse is associated with a failure to establish a new stable homeostatic functional network structure.

Indexed as

BrainHomeostasisNerve NetAgedDefault Mode NetworkFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRecurrence

Identifiers

PMID40442463
PMCPMC12340041

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.